FibroGen's roxadustat fails in 2nd act, endangering AstraZeneca partnership

5th May 2023 Uncategorised 0

FibroGen’s roxadustat fails in 2nd act, endangering AstraZeneca partnership
aliu
Fri, 05/05/2023 – 09:13

More: FibroGen's roxadustat fails in 2nd act, endangering AstraZeneca partnership
Source: fierce